Stock Movers
Stock Movers

Aug 19, 2026 · 5 min

Moderna advances cancer vaccine as rail merger review resumes

Moderna Rises, La-Z Boy Drops, Norfolk Southern Corp Climbs as Regulator Resumes Review of Bid From Rival

The episode connects a promising personalized cancer-vaccine result with consequential corporate outlooks and a revived regulatory review of a major rail bid.

3 key takeaways
  1. 1Moderna’s personalized melanoma vaccine showed stronger recurrence reduction with Keytruda, potentially supporting a regulatory filing as soon as 2027.
  2. 2La-Z-Boy shares fell after the furniture maker issued a weaker-than-expected sales outlook.
  3. 3Norfolk Southern rose as regulators resumed reviewing Union Pacific’s bid and opened a schedule for public participation.

Don't miss

Moderna’s late-stage melanoma-vaccine result showed reduced recurrence when paired with Keytruda, potentially bringing a regulatory filing as soon as 2027.

The brief

Moderna shares rose after a late-stage trial found its personalized melanoma vaccine, used with Merck’s Keytruda, reduced recurrence more effectively than Keytruda alone.

The result could support a regulatory filing as soon as 2027, while La-Z-Boy moved lower after giving investors a weaker-than-expected sales outlook.

Norfolk Southern gained as regulators resumed reviewing Union Pacific’s bid and established a process for public participation in the proposed coast-to-coast freight network.

The episode closes by widening the lens: Economy of Scale examines how AI-enabled systems and Dubai’s long-term urban planning could help cities absorb rapid growth.

What was said on this episode

5 statements · 4 positive · 1 mixed

  1. Ben Weisson La-Z-Boy company-owned storesPositive1:27

    La-Z-Boy’s company-owned stores recorded year-over-year growth.

    “Lazy Boy saw some growth from its company-owned stores, recording a year-over-year jump”

    Listen at 1:27

  2. Ben Weisson La-Z-BoyPositive1:38

    La-Z-Boy generated approximately $500 million in the last quarter.

    “They made like $500 million in the last quarter.”

    Listen at 1:38

  3. Ben Weisson Norfolk Southern and Union Pacific coast-to-coast freight network applicationPositive2:01

    The regulator resumed reviewing Norfolk Southern and Union Pacific’s coast-to-coast freight network application.

    “decided to resume consideration of an application from Norfolk and Union Pacific to create the first coast-to-coast freight network”

    Listen at 2:01

  4. Ben Weisson Norfolk Southern and Union Pacific proposed freight networkMixed2:13

    The proposed freight network could affect shippers, railroads, and the public.

    “how the proposed network could affect shippers, other railroads, and the public”

    Listen at 2:13

  5. Rohit Krishnanon AI in smart citiesPositive3:10

    AI will accelerate and compress processes in smart-city systems.

    “AI will allow in the smart city space to compress a lot of things. The speed will change.”

    Listen at 3:10

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Books & mentions

Economy of Scale

It extends the episode’s closing discussion of AI-enabled cities and Dubai’s urban-development strategy.

Listen to the full episode and explore every guest, topic, and moment on PodLume.

What is PodLume?

PodLume turns podcasts into searchable knowledge. AI-decoded transcripts, identified guests and topics, smart highlights, and cross-show search across the world’s best conversations — all in your pocket.

Moderna advances cancer vaccine as rail merger review resumes | PodLume